Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MicroSectors FANG and Innovation 3X Leveraged ETN vs Oruka Therapeutics Inc. Common Stock — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $32.77 (market cap $2.93B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 20 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FNGU | ORKA | |
|---|---|---|
Market Cap | $2.93B | $5.08B |
Volume | 5,898,696 | 685,276 |
Sector | Leveraged / Inverse | Health |
52-Week High | $37.20 | $113.08 |
52-Week Low | $13.73 | $26.19 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | — | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNGU, a 3X leveraged ETN tracking major tech stocks, trades at $36.69 with a slight 0.22% daily gain. Technical indicators show bullish momentum with strong moving average support, though RSI suggests potential overbought conditions. The ETN provides amplified exposure to technology leaders like Nvidia and Apple, but carries significant volatility risks as highlighted by historical drawdowns.
While leveraged exposure to top tech performers offers growth potential during market rallies, FNGU faces substantial risk from sector volatility and decay effects. The 87% historical decline during tech downturns underscores the importance of risk management for investors considering this high-volatility instrument.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MicroSectors FANG and Innovation 3X Leveraged ETN
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
